Skip to content

Drug Related Problems Among Patients With Femoral Neck Fractures in an Orthopedic Ward

Identification and Characterization of Drug Related Problems Among Patients With Femoral Neck Fractures in an Orthopedic Ward

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01844544
Enrollment
104
Registered
2013-05-01
Start date
2013-06-30
Completion date
2013-10-31
Last updated
2014-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fractures

Keywords

drug related problems, clinical pharmacist, femoral neck fractures, orthopedic patients

Brief summary

the purpose of the study is to: 1. Identify and characterize drug related problems in patients after a femur neck fracture that are hospitalized in the orthopedic department at Meir medical center. 2. Evaluate the contribution of a clinical pharmacist in identifying,characterizing and preventing drug related problems in patients after a femur neck fracture that are hospitalized in the orthopedic department at Meir medical center.

Interventions

OTHERinspection of medical records

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
64 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients over 64 * patients after a femoral neck fracture * patients hospitalized in the orthopedic ward at Meir medical center * patients who speak Hebrew, Russian or English

Exclusion criteria

* patients under 64 * patients without a femoral neck fracture * patients who don't speak Hebrew, Russian or English

Design outcomes

Primary

MeasureTime frame
Evaluate the overall number of drug related problems in patients with a femur neck fracture in the orthopedic departmentparticipants will be followed for the duration of hospital stay, an expected average of 7 days

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026